MeSH tree: C12.100
A class of flu drugs may reduce cognitive decline and premature aging in people living with chronic viral infection, reports a new study led by Northwestern University that began with blood samples from people with HIV and ...
13 hours ago
0
4
How do different cancer subtypes arise? Do they originate from distinct cells, or from a single multipotent cell capable of differentiating into multiple cell types? This question, debated for decades in cancer biology, is ...
Jun 4, 2026
0
2
Prostate cancer screening is one of the most common decisions men face in primary care, yet many patients make that choice without fully understanding the potential benefits and harms. A new editorial by UNC physician experts ...
Jun 4, 2026
0
3
A recent University of Mississippi study has identified hundreds of counties in the South where HIV prevention and health care may not be keeping pace with the local needs, leaving communities without resources to address ...
Jun 3, 2026
0
3
The average woman spends more than one-third of her life in menopause. Some women, however, must deal with menopause-related symptoms longer and face added health problems because of premature menopause (before age 40) or ...
Jun 3, 2026
0
2
Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread attention for effectively treating obesity, lowering blood sugar and decreasing the risk of cardiovascular disease. Some researchers have ...
Jun 3, 2026
0
181
The Society of Interventional Radiology (SIR) has published new practice guidance for the use of prostatic artery embolization (PAE) to treat enlarged prostate (also called benign prostatic hyperplasia or BPH). The guidance ...
Jun 2, 2026
0
3
You've probably heard of Ozempic or Wegovy. These are the injectable drugs that have become household names for weight loss and diabetes.
Jun 2, 2026
0
3
The largest real-world study ever conducted on prostate cancer in Brazil analyzed data from 670,205 patients treated through the Brazilian Unified Health System (SUS) over a 16-year period, between 2008 and 2023. Published ...
Jun 1, 2026
0
4
Previously, immature overall survival results of the NRG Oncology GY018 (NRG-GY018) trial suggested that the use of the immunotherapy drug pembrolizumab in combination with chemotherapy improved overall survival for patients ...
Jun 1, 2026
0
4
